BRCA1 and ovarian carcinoma: Because germ-line pathogenic mutations in BRCA1/2 are a strong genetic risk factor for breast and epithelial ovarian cancer [15], and are associated with disease prognosis and response to treatment [16–18], the individual research results may be regarded as medically important information for patients who do not yet have a diagnostic quality BRCA1/2 test result.